Reta (Research Grade) – Triple Agonist for GIP/GLP-1/Glucagon Pathway Metabolic & Weight-Regulation Studies
 
Reta is a high-purity, research-grade triple agonist targeting the GIP, GLP-1, and glucagon receptors, making it one of the most advanced incretin-based compounds for metabolic research. Its multi-pathway activity provides a powerful platform for studying energy expenditure, glucose regulation, adipose metabolism, appetite control, and weight-management mechanisms in controlled laboratory environments.
 
Researchers use Reta to investigate:
Triple-agonist signaling (GIP/GLP-1/Glucagon)
Metabolic rate and energy-balance modulation
Insulin sensitivity and glucose-control mechanisms
Appetite-regulation pathways and nutrient-intake behavior
Obesity, metabolic-syndrome, and weight-loss research models
 
Syans Bio Lab provides Reta (Research Grade) with exceptional purity, stability, and consistency, ensuring reliable performance across metabolic, endocrine, and incretin-pathway studies.
 
For laboratory research use only. Not for human consumption. Not a drug, dietary supplement, or therapeutic product.
 
Inventory: 15 
Quantity: 10MG , 20MG